| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
UPRESS-EA 971068 (Unité Propre Enseignement Supérieur Associée), Faculté de Médecine, Vandoeuvre, France;
Department of Anesthesia and Intensive Care and
Laboratory of Cellular Biology, Centre Hospitalier Universitaire Brabois, Vandoeuvre, France;
Institut National de la Santé et de la Recherche Médicale Unité 308, Nancy, France; and
¶ Laboratory of Physiology, Hôpital Maison Blanche, Reims, France
NO produced by the inducible NO synthase (NOS2) and prostanoids generated by the cyclooxygenase (COX) isoforms and terminal prostanoid synthases are major components of the host innate immune and inflammatory response. Evidence exists that pharmacological manipulation of one pathway could result in cross-modulation of the other, but the sense, amplitude, and relevance of these interactions are controversial, especially in vivo. Administration of 6 mg/kg LPS to rats i.p. resulted 6 h later in induction of NOS2 and the membrane-associated PGE synthase (mPGES) expression, and decreased constitutive COX (COX-1) expression. Low level inducible COX (COX-2) mRNA with absent COX-2 protein expression was observed. The NOS2 inhibitor aminoguanidine (50 and 100 mg/kg i.p.) dose dependently decreased both NO and prostanoid production. The LPS-induced increase in PGE2 concentration was mediated by NOS2-derived NO-dependent activation of COX-1 pathway and by induction of mPGES. Despite absent COX-2 protein, SC-236, a putative COX-2-specific inhibitor, decreased mPGES RNA expression and PGE2 concentration. Ketoprofen, a nonspecific COX inhibitor, and SC-236 had no effect on the NOS2 pathway. Our results suggest that in a model of systemic inflammation characterized by the absence of COX-2 protein expression, NOS2-derived NO activates COX-1 pathway, and inhibitors of COX isoforms have no effect on NOS2 or NOS3 (endothelial NOS) pathways. These results could explain, at least in part, the deleterious effects of NOS2 inhibitors in some experimental and clinical settings, and could imply that there is a major conceptual limitation to the use of NOS2 inhibitors during systemic inflammation.
This article has been cited by other articles:
|
|
 |
|
  B. Samuelsson, R. Morgenstern, and P.-J. Jakobsson Membrane Prostaglandin E Synthase-1: A Novel Therapeutic Target Pharmacol. Rev., September 1, 2007; 59(3): 207 - 224. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Feleder, V. Perlik, and C. M. Blatteis Preoptic nitric oxide attenuates endotoxic fever in guinea pigs by inhibiting the POA release of norepinephrine Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2007; 293(3): R1144 - R1151. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Aisemberg, C. Vercelli, S. Billi, M. L. Ribeiro, D. Ogando, R. Meiss, S. M. McCann, V. Rettori, and A. M. Franchi Nitric oxide mediates prostaglandins' deleterious effect on lipopolysaccharide-triggered murine fetal resorption PNAS, May 1, 2007; 104(18): 7534 - 7539. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A.-K. Larsson, M. Back, J. Hjoberg, and S.-E. Dahlen Inhibition of Nitric-Oxide Synthase Enhances Antigen-Induced Contractions and Increases Release of Cysteinyl-Leukotrienes in Guinea Pig Lung Parenchyma: Nitric Oxide as a Protective Factor J. Pharmacol. Exp. Ther., October 1, 2005; 315(1): 458 - 465. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Masse, S. Guiral, L.-J. Fortin, E. Cauchon, D. Ethier, J. Guay, and C. Brideau An Automated Multistep High-Throughput Screening Assay for the Identification of Lead Inhibitors of the Inducible Enzyme mPGES-1 J Biomol Screen, September 1, 2005; 10(6): 599 - 605. [Abstract] [PDF]
|
|
|
|
 |
|
 H. Kim, S. H. Rhee, E. Kokkotou, X. Na, T. Savidge, M. P. Moyer, C. Pothoulakis, and J. T. LaMont Clostridium difficile Toxin A Regulates Inducible Cyclooxygenase-2 and Prostaglandin E2 Synthesis in Colonocytes via Reactive Oxygen Species and Activation of p38 MAPK J. Biol. Chem., June 3, 2005; 280(22): 21237 - 21245. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I.-H. Pang, E. C. Johnson, L. Jia, W. O. Cepurna, A. R. Shepard, M. R. Hellberg, A. F. Clark, and J. C. Morrison Evaluation of Inducible Nitric Oxide Synthase in Glaucomatous Optic Neuropathy and Pressure-Induced Optic Nerve Damage Invest. Ophthalmol. Vis. Sci., April 1, 2005; 46(4): 1313 - 1321. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Rouzer, P. J. Kingsley, H. Wang, H. Zhang, J. D. Morrow, S. K. Dey, and L. J. Marnett Cyclooxygenase-1-dependent Prostaglandin Synthesis Modulates Tumor Necrosis Factor-{alpha} Secretion in Lipopolysaccharide-challenged Murine Resident Peritoneal Macrophages J. Biol. Chem., August 13, 2004; 279(33): 34256 - 34268. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Uno, Y. Iuchi, J. Fujii, H. Sugata, K. Iijima, K. Kato, T. Shimosegawa, and T. Yoshimura In Vivo Study on Cross Talk between Inducible Nitric-Oxide Synthase and Cyclooxygenase in Rat Gastric Mucosa: Effect of Cyclooxygenase Activity on Nitric Oxide Production J. Pharmacol. Exp. Ther., June 1, 2004; 309(3): 995 - 1002. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Ghosh, A. Stewart, D. E. Tucker, J. V. Bonventre, R. C. Murphy, and C. C. Leslie Role of Cytosolic Phospholipase A2 in Prostaglandin E2 Production by Lung Fibroblasts Am. J. Respir. Cell Mol. Biol., January 1, 2004; 30(1): 91 - 100. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. I. Ivanov, R. S. Pero, A. C. Scheck, and A. A. Romanovsky Prostaglandin E2-synthesizing enzymes in fever: differential transcriptional regulation Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2002; 283(5): R1104 - R1117. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Ahmad, L. C. Chen, M. A. Gordon, J. D. Laskin, and D. L. Laskin Regulation of cyclooxygenase-2 by nitric oxide in activated hepatic macrophages during acute endotoxemia J. Leukoc. Biol., June 1, 2002; 71(6): 1005 - 1011. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Funakoshi, T. Kubota, N. Kawamura, Y. Machida, A. M. Feldman, H. Tsutsui, H. Shimokawa, and A. Takeshita Disruption of Inducible Nitric Oxide Synthase Improves {beta}-Adrenergic Inotropic Responsiveness but Not the Survival of Mice With Cytokine-Induced Cardiomyopathy Circ. Res., May 17, 2002; 90(9): 959 - 965. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
